BetaEval Global: Prospective, Multinational, Observational Cohort Study of Patients Using BETACONNECT(®)

PURPOSE: Patients with multiple sclerosis (MS) would benefit from continued long-term treatment with disease-modifying therapies, and autoinjectors may help improve patients’ satisfaction with therapy, thereby increasing adherence rates. BETACONNECT(®) is an autoinjector for interferon beta-1b desig...

Descripción completa

Detalles Bibliográficos
Autores principales: Patti, Francesco, Martínez Ginés, María Luisa, Norenberg, Christiane, Duarte Caron, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196206/
https://www.ncbi.nlm.nih.gov/pubmed/32425509
http://dx.doi.org/10.2147/PPA.S245955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196206/
https://www.ncbi.nlm.nih.gov/pubmed/32425509
http://dx.doi.org/10.2147/PPA.S245955

Ejemplares similares